nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.07.2009 | Original Paper

Integrin β3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones

verfasst von: Jie Chen, Jie Zhang, Yaoran Zhao, Jun Li, Maosun Fu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the role of integrin β3 in invasive features of ovarian cancer SKOV3 cells, by comparing different metastatic subclones.

Methods

In the present study, two cell subclones, termed as S1 and S21, which possessed high and low metastatic potential, respectively, were isolated and established from human ovarian cancer parental cell line SKOV3 by the limited dilution method. The expressions of integrin αv, integrin αvβ3, integrin β3, E-cadherin, FAK and ILK in the two cell subclones were compared by means of real-time RT-PCR or flow cytometry. Subsequently, S21 was transfected with siRNA for integrin β3 and the effects of transfection were examined by methyl thiazolyl tetrazolium (MTT) assay, colony formation assay, Matrigel invasion assay and cell migration assay.

Results

The expressions of integrin αvβ3, integrin β3 and E-cadherin were markedly down-regulated in S1; however, there were no significant differences in the expressions of integrin αv, FAK and ILK β. Of note, more than 70% knockdown of integrin β3 expression was obtained by siRNA technique. The integrin β3-siRNA-transfected cells showed significant increases in cell proliferation, cell migration and invasive activity in contrast with the mock-transfected cells. The expressions of integrin αvβ3 and E-cadherin were lower in the integrin β3-siRNA-transfected cells compared to the mock control.

Conclusion

Integrin β3, like E-cadherin, may be also a suppressor gene down-regulating invasive features of ovarian cancer cells in SKOV3 cell subclones.

Albini A, Iwamoto Y, Kleinman HK et al (1987) Arapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245PubMed

Arnaout MA (2002) Integrin structure: new twists and turns in dynamic cell adhesion. Immunol Rev 186:125–140. doi:10.1034/j.1600-065X.2002.18612.x PubMedCrossRef

Bauer K, Mierke C, Behrens J (2007) Expression profiling reveals genes associated with transendothelial migration of tumor cells: a functional role for alphavbeta3 integrin. Int J Cancer 121:1910–1918. doi:10.1002/ijc.22879 PubMedCrossRef

Baum O, Hlushchuk R, Forster A, Greiner R, CléZardin P, Zhao Y et al (2007) Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit. Int J Oncol 30:325–332PubMed

Bian B, Ma C, You J, Ning J, Fang W, Zheng J (2003) The effects of TMSG-1 gene transfection on metastatic phenotype of pg cancer cells. Beijing Da Xue Xue Bao 35:18–22PubMed

Bojesen SE, Kjaer SK, Høgdall EV et al (2005) Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes. Endocr Relat Cancer 12(4):945–952. doi:10.1677/erc.1.01083 PubMedCrossRef

Brun JL, Feyler A, Chêne G, Saurel J, Brun G, Hocké C (2000) Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 78:21–27. doi:10.1006/gyno.2000.5805 PubMedCrossRef

Brüning A, Köhler T, Quist S, Wang-Gohrke S, Moebus VJ, Kreienberg R et al (2001) Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. Hum Gene Ther 12:391–399. doi:10.1089/10430340150504019 PubMedCrossRef

Carreiras F, Rigot Y, Cruet S et al (1999) Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha (v) beta3 integrins and vitronectin. Int J Cancer 80:285–294. doi :10.1002/(SICI)1097-0215(19990118)80:2<285::AID-IJC19>3.0.CO;2-LPubMedCrossRef

Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C, Dedhar S (2003) Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22:1688–1702. doi:10.1038/sj.onc.1206347 PubMedCrossRef

D’Abaco GM, Kaye AH (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci 14:1041–1048. doi:10.1016/j.jocn.2007.06.019 PubMedCrossRef

Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197:893–895. doi:10.1126/science.887927 PubMedCrossRef

Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G H. A. Clowes Memorial Award Lecture. Cancer Res 50:6130–6138PubMed

Geiger B, Bershadsky A, Pankov R, Yamada KM (2001) Transmembrane crosstalk between the extracellular matrix–cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2:793–805. doi:10.1038/35099066 PubMedCrossRef

Grzesiak JJ, Ho JC, Ar Moossa, Bouvet M (2007) The integrin–extracellular matrix axis in pancreatic cancer. Pancreas 35:293–301PubMedCrossRef

Hapke S, Kessler H, Luber B et al (2003) Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction. Biol Chem 384:1073–1083. doi:10.1515/BC.2003.120 PubMedCrossRef

Horiuchi A, Konishi I (2004) Mechanism of ovarian cancer metastasis: changes in E-cadherin expression. Nippon Rinsho 62:463–466PubMed

Hata F, Nishimori H, Yasoshima T, Tanaka H, Ohno K, Yanai Y et al (2004) Profiling analysis of differential gene expression between hematogenous and peritoneal metastatic sublines of human pancreatic cancer using a DNA chip. J Exp Clin Cancer Res 23:513–520PubMed

Jakubowska A, Gronwald J, Menkiszak J et al (2007) Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. J Med Genet 44:408–411. doi:10.1136/jmg.2006.047498 PubMedCrossRef

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef

Kallio JP, Mikkelsson J, Tammela TL, Karhunen PJ, Kellokumpu-Lehtinen P (2006) Genetic variation in platelet integrin alphabeta (GPIIb/IIIa) and the metastatic potential of renal cell carcinoma. BJU Int 98:201–204. doi:10.1111/j.1464-410X.2006.06196.x PubMedCrossRef

Kanamori M, Vanden Berg SR, Bergers G, Berger MS, Pieper RO (2004) Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. Cancer Res 64:2751–2758. doi:10.1158/0008-5472.CAN-03-3354 PubMedCrossRef

Kasirer-Friede A, Kahn ML, Shattil SJ (2007) Platelet integrins and immunoreceptors. Immunol Rev 218:247–264. doi:10.1111/j.1600-065X.2007.00532.x PubMedCrossRef

Kee SH, Steinert PM (2001) Microtubule disruption in keratinocytes induces cell–cell adhesion through activation of endogenous E-cadherin. Mol Biol Cell 12:1983–1993PubMed

Knudsen KA, Soler AP, Johnson KR, Wheelock MJ (1995) Interaction of alpha-actinin with the cadherin/catenin cell–cell adhesion complex via alpha-catenin. J Cell Biol 130:67–77. doi:10.1083/jcb.130.1.67 PubMedCrossRef

Le Tourneau C, Faivre S, Raymond E (2007) The role of integrins in colorectal cancer. Oncology 21:21–24 Williston ParkPubMed

Legate KR, Montañez E, Kudlacek O, Fässler R (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7:20–31. doi:10.1038/nrm1789 PubMedCrossRef

Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ (1994) E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci 107:3615–3621PubMed

Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J et al (2003) Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 129:43–51. doi:10.1007/s00432-003-0493-z PubMedCrossRef

Li SG, Ye ZY, Zhao ZS, Tao HQ, Wang YY, Niu CY (2008) Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma. World J Gastroenterol 14:421–427. doi:10.3748/wjg.14.421 PubMedCrossRef

Liapis H, Adler LM, Wick MR, Rader JS (1997) Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum Pathol 28:443–449. doi:10.1016/S0046-8177(97)90033-2 PubMedCrossRef

Liu Y, Zheng J, Fang W, You J, Wang J, Cui X et al (2001) Identification of metastasis-associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic. Chin Med J 114:35–38PubMed

Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:516–523. doi:10.1016/j.ceb.2006.08.011 PubMedCrossRef

Nakano T, Tani M, Ishibashi Y, Kimura K, Park YB et al (2003) Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis 20:665–674. doi:10.1023/A:1027355610603 PubMedCrossRef

Neto DS, Pantaleão L, de Sá BC, Landmam G (2007) Alpha-v-beta3 integrin expression in melanocytic nevi and cutaneous melanoma. J Cutan Pathol 34:851–856. doi:10.1111/j.1600-0560.2007.00730.x PubMedCrossRef

Parise LV, Lee J, Juliano RL (2000) New aspects of integrin signaling in cancer. Semin Cancer Biol 10:407–414. doi:10.1006/scbi.2000.0337 PubMedCrossRef

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef

Radinsky R, Weisberg HZ, Staroselsky AN, Fidler IJ (1992) Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res 52:5808–5814PubMed

Robertson JH, Am Iga, Sales KM, Winslet MC, Seifalian AM (2008) Integrins: a method of early intervention in the treatment of colorectal liver metastases. Curr Pharm Des 14:296–305. doi:10.2174/138161208783413284 PubMedCrossRef

Sato T, Miwa A (2002) Ets-1 and integrin beta3 for lung metastasis from colorectal cancer. APMIS 110:347–353. doi:10.1034/j.1600-0463.2002.100410.x PubMedCrossRef

Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR et al (2004) Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol 165:1087–1095PubMed

Switala-Jelen K, Dabrowska K, Opolski A, Lipinska L, Nowaczyk M, Gorski A (2004) The biological functions of beta3 integrins. Folia Biol (Praha) 50:143–152

Tanaka H, Hata F, Nishimori H, Honmou O, Yasoshima T, Nomura H et al (2003) Differential gene expression screening between parental and highly metastatic pancreatic cancer variants using a DNA microarray. J Exp Clin Cancer Res 22:307–313PubMed

Tucker GC (2002) Inhibitors of integrins. Curr Opin Pharmacol 2:394–402. doi:10.1016/S1471-4892(02)00175-3 PubMedCrossRef

Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT et al (2006) Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol 59:460–467. doi:10.1136/jcp.2005.029876 PubMedCrossRef

Watson-Hurst K, Becker D (2006) The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol Ther 5:1375–1382PubMed

Wu C, Cipollone J, Maines-Bandiera S, Tan C, Karsan A, Auersperg N et al (2008) The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression. Differentiation 76:193–205. doi:10.1111/j.1432-0436.2007.00193.x PubMedCrossRef

Zhang Q, Furukawa K, Chen HH, Fujinawa R, Kozutsumi Y et al (2006) Down-regulation of caveolin-1 in mouse Lewis lung cancer P29 is a causal factor for the malignant properties in a high-metastatic subline. Oncol Rep 16:289–294PubMed

Titel: Integrin β3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones
verfasst von: Jie Chen
Jie Zhang
Yaoran Zhao
Jun Li
Maosun Fu
Publikationsdatum: 01.07.2009
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2009
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-008-0526-8

Springer Medizin

Integrin β3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2009

High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation

Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI

Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death

Down-regulation of plasma membranous Annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: correlation with epithelial differentiation

Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie